Embleema

Embleema

Created using Figma

Última atualização

31 de out. de 2018

Seu histórico médico é inviolável e sempre disponível graças aos recursos de segurança e distribuição de dados do Blockchain
Você escolhe quais provedores podem ver qual parte do seu histórico médico e você sabe exatamente quem acessou e quando
Sua privacidade está totalmente protegida de uma maneira compatível com HIPAA
Private Sale
out., 2018
mar., 2019
100% completou
Fundos arrecadados - sem dados
309
objetivo 20 000 000.00 USD
Boné 2 000 000.00 USD
Capa dura 30 000 000.00 USD
past
  • 1 RWD
    =
    0.2 USD
Detalhes do token
Ticker
RWD
Moedas Aceitas
ETH, BTC, BCH, FIAT
Detalhes da Companhia
Nome da empresa registrada
Embleema Inc
País registrado
United States, France
Empresa fundada
Jun 1, 2017
detalhes adicionais
MVP / Protótipo
sim
Plataforma
Ethereum
KYC
sim
Categorias
Saúde

Sobre Embleema

Nós acreditamos que a tecnologia Blockchain é o padrão ideal que pode fornecer aos pacientes, profissionais de saúde, pagadores de seguros de saúde e provedores uma visão compartilhada, abrangente, longitudinal e confiável do histórico médico de um paciente. Quando preservado como um razão de transações, o histórico médico de um paciente é claramente acessível para todas as partes interessadas com a devida autorização do paciente e a melhor opção de tratamento pode ser determinada.

PatientTruth & trade; é uma solução de software baseada em Cloud e Blockchain que se conecta aos diferentes registros médicos de um paciente nos vários centros de serviços de saúde, como hospitais, práticas de cuidados primários, centros de reabilitação, lares de idosos e centros de atendimento de urgência, e os encadeia em um consistente, História médica abrangente e inviolável. PatientTruth & trade; fornece uma visão holística do histórico médico de um paciente em provedores e centros de atendimento.

Características

Patients can:

• Register and sign-on through the Patient Dapp interface,

• Upload their health records in the Blockchain, • Visualize their patient record,

• Authorize the sharing of their identified patient record to providers,

• Expose and sell their health records in the Marketplace against RWE tokens,

• Visualize a full audit-trail on their patient record access and health records sold,

• Visualize a statement of his/her RWE transactions.

 

Providers can:

• Register and sign-on through the Provider Dapp interface,

• Visualize an identified patient record, with due consent from the patient,

• Perform a health record quality check, when requested by the health record data owner,

• Visualize a statement of his/her RWE transactions,

 

Care Centers and other Data Owners can:

• Register and sign-on through the Data Owner Dapp interface,

• Have their health records indexed into the Blockchain and linked to patients,

• Expose and sell their health records in the Marketplace against RWE tokens, with due consent from the patients,

• Visualize a statement of RWE transactions,

 

Pharma companies, Payers and other Data Buyers can:

• Register and sign-on through the Data Buyer Dapp interface,

• Expose their inclusion criteria for health record purchases,

• Browse a list of data owners which own health records matching their inclusion criteria,

• Select the data owners they wish to purchase health records from,

• Execute the purchase in RWE tokens with data owners,

• Visualize a statement of RWE transactions,

 

Pharma companies and authorities can:

• Register and sign-on through the Real-World Evidence Dapp interface,

• Pharma companies register health products on which they wish to share with authorities Real-World Evidence, and define the patient records they wish to share,

• Authorities can visualize the shared Real-World Evidence from Pharma companies.

We expect Version 2 to be HIPAA compliant (see “Embleema and Privacy Compliance section” below) for the U.S. users and GDPR compliant for the European users. Version 2 will include health records from U.S. patients. Version 2 is planned to launch in Q3 2019.

Informações técnicas

O Embleema Health Blockchain Version 2 contém os seguintes recursos:


& bull; Contratos inteligentes específicos de assistência à saúde que gerenciam o consentimento do paciente, armazenamento de registros de saúde, armazenamento e compartilhamento de registros de pacientes (identificados e identificados), auditoria de acesso a registros de pacientes e o Marketplace,
> & bull; Token RWE integrado gerado pelo Blockchain para transações e outras recompensas. As transações de tokens RWE não exigem pagamento de taxa do remetente e têm um tempo de mineração previsível,
& bull; APIs e analisadores de registros de saúde para integrar no Blockchain várias entradas de formato de dados para registros de saúde como HL 7 FHIR, CCD, formatos de dispositivos proprietários conectados e outros formatos de registro de saúde,
& bull; Escalabilidade: até 2 milhões de pacientes para o mercado dos EUA,
& bull; Desempenho: a visualização dos registros de saúde deve ocorrer em
2 segundos, a mineração no Blockchain deve ocorrer em 5 segundos,
a reconciliação de compradores de dados com critérios de inclusão de proprietários de dados
no Marketplace deve ocorrer em menos de 1 minuto , outro lote
de processamento, como a análise e a indexação de fontes de dados, será avaliado em termos de desempenho para cada fonte de dados.

Contrato inteligente exposto aos participantes da rede:
& bull; Registro de Saúde: escreva, leia um registro de saúde no Blockchain,
& bull; Registro do paciente: conecte registros de saúde a um determinado paciente, leia o registro do paciente no Blockchain,
& bull; Consentimento do paciente: define a autorização do paciente para compartilhar seus registros de saúde (identificados e identificados),
& bull; Trilha de Auditoria: fornece aos proprietários dos dados uma trilha de auditoria dos acessos
aos seus registros de saúde,
& bull; Mercado: expõe metadados de registros de saúde de proprietários de dados
após a devida autorização de pacientes, permite que os compradores de dados pesquisem
registros de saúde para compra, corresponda a compradores de dados & rsquo; critérios de inclusão
com registros de proprietários de dados, executa transações de compra
entre compradores de dados e proprietários de dados,
& bull; RWE token smart-contract: emite tokens RWE como recompensas por
proprietários de dados para armazenar registros de saúde no Blockchain (primeiros 3 anos)

% name% Roadmap

  • Embleema’s growth plan

  • Embleema has already launched the first patient Blockchain.

    Version 1 is publicly accessible at https://patienttruth.embleema.com
    and contains the following functionalities:
    • Upload HL7 Continuity of Care Documents (CCD) medical records
    into blockchain by patients (U.S. patients only),
    • Upload of Fitbit information into blockchain by patients,
    • Consolidation of CCDs (U.S. patients only) and Fitbit information
    into a Medical history stored securely on blockchain,
    • Authorization management from patients for the sharing of their
    Medical history with providers,
    • Visualization by providers of patients’ Medical histories after due
    authorization from patients,
    • Audit-trail for patients of Medical history accesses by providers,
    • Compensation to patients in EBL tokens for uploading CCDs
    (U.S. patients only) and Fitbit information, as well as referrals of
    new patients and providers.

    Version 1 will be used to pilot and prove in real-life the relevance of
    the 2 key concepts carried by the Embleema Health Blockchain:
    • Patients have control of their health records and may share and
    sell their data to pharma companies: this pilot will start in September
    2018 with cysticfibrosis.com, a U.S. based patient community in
    Cystic Fibrosis (announced on July 17, 2018: https://medcitynews.
    com/2018/07/embleema-emerges-from-stealth-mode-launchesblockchain-
    based-health-record-system/),
    • Pharma companies and regulators share the next generation of
    RWE: real-time, individual-patient level 360 view medical histories,
    with continuous monitoring of the same patient and his/her full
    and trusted consent: this pilot will start in January 2019 with
    a top-5 global pharma company and a leading health regulator
    (announcement planned in Q4 2018).
  • End of 2019

  • End of 2019, Embleema expects to expand its Blockchain to the French
    market and the China marketplace with its 800 million connected patient
    population by striking a set of strategic distribution partnerships with major
    local players in the healthcare and technology industry.
  • Q3 2019

  • Concurrently to its V2 launch in Q3 2019, Embleema plans to set up consulting
    services for pharmaceuticals and health network to facilitate the
    adoption of blockchain in their processes and systems.
  • 2021

  • In 2021, Embleema plans to launch V3 of its Health Blockchain Network
    which will able to integrate mining nodes from pharma companies, payers
    and care centers. V3 will also implement an API allowing third party patient
    app providers to connect to the Blockchain and offer personalized services
    to patients through the Blockchain.
  • consulte Mais informação
  • 2022

  • For 2022, with a critical mass of patient records stored onto the Blockchain,
    Embleema plans to offer advanced analytics services for various purposes:
    population health, observational studies, safety studies. Embleema will also
    start researching the possibility of offering predictive medicine services
    based on the wealth of data stored in the Blockchain.

Embleema Equipe

Verificado 100%

Robert Chu
Founder, CEO and CTO
verificado
Prashant Khambekar,...
Chief Blockchain Development Executive
verificado
Pradeep Sreekanthan
Chief Delivery Officer
verificado
Vincent Galand
Manager, Operations
verificado
Pascal Becache
Business Development Executive
verificado
Nicolas Schmidt
Chief Product Officer
verificado
Alexis Normand
Head of Blockchain Consortium
verificado

Assessores

Verificado 29%

Atenção. Existe o risco de os membros não verificados não serem realmente membros da equipe

Vahan Simonyan, Phd
Advisor | Chief Scientist - WHISE-Embleema Health...
não verificado
Frederic Duchesne, P...
Advisor | CEO of Pierre Fabre Pharmaceuticals
não verificado
Atakan Seçkin
Advisor | User Experience
verificado
Pr. John Halamka, Md
Advisor | Professor of Innovation at Harvard Medic...
não verificado
Adel Al-Saleh
Advisor | CEO of T-Systems and Board Member of Deu...
não verificado
Bernard Gilly, Phd
Advisor | CEO at GenSight Biologics & Chairman at...
não verificado

2 ICO

$12 158 963

Lorenzo Nardiello
Social Media Manager
verificado

Embleema Entrevistas

Atakan Seçkin
As a team member, сan you tell us about your role in the ICO project?
Branding, UI/UX design and implementation of PatientTruth (since POC to product launch) ICO dashboard and future projects
What do you think about idea?
I've designed several products in healthcare industry prior to this project, and none of those projects placed the patient in the center - information asymmetry is a real problem. I believe blockchain with thoughtful design can enable patients to do so much more with their data - not only in terms of being aware, but also the control to choose who can see your data, and monetize it on your own terms and no one else's. We know we have a long road ahead, but I have confidence that we have the best team in the world to be making this product, and we can evolve it in a way that will disrupt existing industries.
Lorenzo Nardiello
As a team member, сan you tell us about your role in the ICO project?
I am in charge of the social media : Telegram, Bitcointalk, Reddit, Discord ... I also organize the bounty program that will come soon and manage our ambassador.
What do you think about idea?
Imagine a world in which you can contribute to medical research and create safer, less expensive and faster new treatments against cancer and rares diseases. Imagine a tamper-proof, holistic, longitudinal and patient-centric worldwide health record interfacing with medical researchers, health regulators, physicians, care centers and the pharmaceutical industry.
Robert Chu
As a team member, сan you tell us about your role in the ICO project?
Founder and CEO of Embleema
I am responsible for overall product strategy, go-to-market and sales of our Embleema Health Blockchain which was launched publicly in July 2018
What do you think about idea?
Embleema Health Blockchain helps patients to advance clinical research by securely sharing their data to pharmaceutical companies during real-world evidence and clinical trial studies. Pharmaceutical companies benefit from faster and more precise data which they can in turn share with regulators such as the U.S. Food and Drug Administration (FDA). Ultimately, patients receive innovative treatments sooner, this is the meaning of our work.
Prashant Khambekar, PhD
As a team member, сan you tell us about your role in the ICO project?
I handle the blockchain development. This includes the ICO/token part.

I also help determine the strategy of the company and its products.
What do you think about idea?
It is a wonderful idea whose time has come. Patients should have the right to control their own health data. The token mechanism helps maintain third-party oversight into the Embleema products.
Pradeep Sreekanthan
As a team member, сan you tell us about your role in the ICO project?
Delivering different versions of the platform. Making the customer experience delightful and easy. Working with various teams.
What do you think about idea?
Revolutionary - bringing healthcare to the blockchain is unusual and will be quite disruptive. RWE in particular.
Vincent Galand
As a team member, сan you tell us about your role in the ICO project?
I am Ops Manager at Embleema Inc. and run Embleema’s ICO operations, coordinating the team of technical experts, legal advisors, social media marketing manager and contractors around the project. I am also developping the business in Europe with pharma companies.
What do you think about idea?
I believe blockchain’s decentralisation power will disrupt the healthcare industry allowing everyone to participate to the advancement of medical progresses. Moreover, we developped a real, concrete industrial use case of Blockchain technology to accelerate medical research, e.g. Real World Evidence / Phase IV clinical trials. We are the only ICO project with a product already available on the market (PatientTruth), first major clients (Pierre Fabre, Servier, others coming soon) and a full support from the medical research community, the pharmaceutical industry and patient associations.
Pascal Becache
As a team member, сan you tell us about your role in the ICO project?
In France and Europe : Investors relations, business development, relations with Pharma companies. As a former IBM and IMS Health executive, I unveil the value of the patient data blockchain for investors, pharmaceutical companies, public and private health insurances and regulators.
What do you think about idea?
Embleema is the future of medical, drugs and population health studies. It will disintermediate collection and use of health data, allowing more, faster, cheaper and more ethical and transparent research benefiting to patients and healthcare systems. It complies with all regulatory aspects in the countries they enter.
Nicolas Schmidt
As a team member, сan you tell us about your role in the ICO project?
I'm Chief Product Officer at Embleema: I lead of our next product development, translate users and customers' needs into a world-class product and manage our marketing.
What do you think about idea?
We're the only healthcare project with a blockchain solution in production, valuable data on usage, several pharma companies as customers and a team of world-class advisors. We achieved all of this before launching our ICO in order to reduce risks for potential subscribers.
Alexis Normand
As a team member, сan you tell us about your role in the ICO project?
I bring together patient advocacy groups & life sciences researchers and regulatoirs to create a decentralized marketplace for health data, to replace the slow, manual and costly process of collecting real world evidence (RWE) for late stage clinical research
What do you think about idea?
Allowing patients to opt-in to pharma research along their own terms is game changing. Only blockchain allows patients to assemble the full picture of their health data, own and share it, and be compensated for their active involvement in clinical research.

Embleema Últimas notícias

  • Como pode haver diferenças de horário nas atualizações de informações, informações precisas sobre cada projeto da OIC devem ser verificadas por meio de seu site oficial ou de outros canais de comunicação.
  • Esta informação não é uma sugestão ou conselho para investir no financiamento da OIC. Por favor, investigue completamente as informações relevantes e decida sobre a participação da OIC.
  • Se você acha que há problemas ou problemas a serem corrigidos neste conteúdo, ou se gostaria de enviar seu próprio projeto da OIC para ser listado, envie-nos um e-mail. um>
Leia o aviso e o aviso de risco. Mostrar aviso legal e aviso de risco.